<?xml version="1.0"?>
      <template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
        <id>994f58cd-7566-4d76-b78d-9b3ed4a5c4e9</id>
        <name>COVID-19 ICU Antibacterial Therapy Order Group</name>
        <description>
          <lifecycle_state>Initial</lifecycle_state>
          <details>
            <purpose/>
            <use/>
            <misuse/>
          </details>
          <other_details>
            <item>
              <key>MetaDataSet:Sample Set </key>
              <value>Template metadata sample set </value>
            </item>
            <item>
              <key>Acknowledgements</key>
              <value/>
            </item>
            <item>
              <key>Business Process Level</key>
              <value/>
            </item>
            <item>
              <key>Care setting</key>
              <value/>
            </item>
            <item>
              <key>Client group</key>
              <value/>
            </item>
            <item>
              <key>Clinical Record Element</key>
              <value/>
            </item>
            <item>
              <key>Copyright</key>
              <value/>
            </item>
            <item>
              <key>Issues</key>
              <value/>
            </item>
            <item>
              <key>Owner</key>
              <value/>
            </item>
            <item>
              <key>Sign off</key>
              <value/>
            </item>
            <item>
              <key>Speciality</key>
              <value/>
            </item>
            <item>
              <key>User roles</key>
              <value/>
            </item>
          </other_details>
        </description>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
          <items>
            <item>
              <key>Technical.ï»© Technical Traceability</key>
              <value>{~AHSID~994f58cd-7566-4d76-b78d-9b3ed4a5c4e9~NAME~COVID-19 ICU Antibacterial Therapy Order Group}</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
          <items>
            <item>
              <key>CKT.Clinical Guidance</key>
              <value>&lt;p&gt;&amp;nbsp;The use of empiric antibacterial therapy should be reserved for suspected or confirmed bacterial infection. Antibacterials should be reassessed within the first 3 days after initiation to determine if continuation is necessary, or to de-escalate and/or optimize therapy in accordance with the principles of stewardship to avoid short-term adverse-effects and negative long-term consequences of increased microbial resistance.&lt;br&gt;Doxycycline and linezolid are not routinely used in pregnancy.&amp;nbsp;&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Empiric Antimicrobial Therapy of Pneumonia in Hospitalized Suspect COVID-19 Patients&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
          <items>
            <item>
              <key>CKT.Clinical Guidance</key>
              <value>&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;em&gt;REASSESS WITH VIRAL AND BACTERIAL LAB RESULTS&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;Pending confirmation COVID-19 positive AND bacterial culture negative. &lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;em&gt;For pregnant patients - choose Azithromycin. Doxycycline NOT recommended&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;em&gt;&lt;strong&gt;cefTRIAXone&lt;/strong&gt; - if patient greater than 100 kg, give 2 g every 24 hours&lt;/em&gt;&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Empiric Antimicrobial Therapy of Pneumonia in Hospitalized Suspect COVID-19 Patients&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
          <items>
            <item>
              <key>CKT.Content Details</key>
              <value>&lt;p&gt;IF patient greater than 100kg, give 2g every 24 hours&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Empiric Antimicrobial Therapy of Pneumonia in Hospitalized Suspect COVID-19 Patients&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0156]">
          <items>
            <item>
              <key>Transform.Preselected</key>
              <value>&lt;p&gt;Y&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Empiric Antimicrobial Therapy of Pneumonia in Hospitalized Suspect COVID-19 Patients&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;doxycycline oral&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;doxycycline Capsule; 200 mg, oral, once&apos;]/activities[at0156]">
          <items>
            <item>
              <key>Transform.Preselected</key>
              <value>&lt;p&gt;Y&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Empiric Antimicrobial Therapy of Pneumonia in Hospitalized Suspect COVID-19 Patients&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;doxycycline oral&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;doxycycline Capsule; 100 mg, Oral, 2 times per day, for 5 doses. Starting 12 hours following initial 200 mg dose. Reassess after 48 to 72 hours&apos;]/activities[at0156]">
          <items>
            <item>
              <key>Transform.Preselected</key>
              <value>&lt;p&gt;Y&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Empiric Antimicrobial Therapy of Pneumonia in Hospitalized Suspect COVID-19 Patients&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;doxycycline liquid&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;doxycycline oral liquid 5 mg/mL; 200 mg, oral, once, STAT&apos;]/activities[at0156]">
          <items>
            <item>
              <key>Transform.Preselected</key>
              <value>&lt;p&gt;Y&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;Empiric Antimicrobial Therapy of Pneumonia in Hospitalized Suspect COVID-19 Patients&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;doxycycline liquid&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;doxycycline oral liquid 5 mg/mL; 100 mg, oral, 2 times per day for 6 doses,  Starting 12 hours following initial 200 mg dose. Reassess after 48 to 72 hours&apos;]/activities[at0156]">
          <items>
            <item>
              <key>Transform.Preselected</key>
              <value>&lt;p&gt;Y&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;ADD if history of MRSA or high suspicion MRSA&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;vancomycin IV&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
          <items>
            <item>
              <key>CKT.Clinical Guidance</key>
              <value>&lt;p&gt;Recommended dosing frequency for vancomycin q8-12 hours. Refer to Bugs and Drugs (http://bugsanddrugs.org/) for frequency adjustments based on creatinine clearance.&amp;nbsp;&lt;/p&gt;&lt;p&gt;Recommended loading dose 25 to 30 mg/kg/dose, maximum 3000 mg/dose.&lt;/p&gt;&lt;p&gt;Recommended maintenance dose 15 mg/kg/dose&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;ADD if history of MRSA or high suspicion MRSA&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;vancomycin IV&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;vancomycin injection; 25 mg/kg/dose, intravenous, once, STAT&apos;]/activities[at0001]">
          <items>
            <item>
              <key>CKT.Content Details</key>
              <value>&lt;p&gt;&lt;em&gt;Discontinue vancomycin or linezolid if MRSA carriage swab and bacterial respiratory cultures are negative for MRSA.&lt;/em&gt;&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;ADD if history of MRSA or high suspicion MRSA&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;vancomycin IV&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;vancomycin injection; 15 mg/kg/dose, intravenous, every 12 hours, for 3 days. Start 12 hours after initial 25 mg/kg/dose dose. Target trough. Reassess in 48 to 72 hours. &apos;]/activities[at0001]">
          <items>
            <item>
              <key>CKT.Content Details</key>
              <value>&lt;p&gt;&lt;em&gt;Discontinue vancomycin or linezolid if MRSA carriage swab and bacterial respiratory cultures are negative for MRSA.&lt;/em&gt;&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;ADD if history of MRSA or high suspicion MRSA&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;linezolid&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
          <items>
            <item>
              <key>CKT.Clinical Guidance</key>
              <value>&lt;p&gt;All patients with functional GI tract should use oral formulation, use IV formulation only if non-functional GI tract.&lt;/p&gt;&lt;p&gt;Alternate if renal dysfunction or known prior MRSA pneumonia&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;ADD if history of MRSA or high suspicion MRSA&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;linezolid&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;linezolid injection; 600 mg, intravenous, every 12 hours, for 6 doses, STAT&apos;]/activities[at0001]">
          <items>
            <item>
              <key>CKT.Content Details</key>
              <value>&lt;p&gt;&lt;em&gt;Reassess in 48 to 72 hours. Discontinue vancomycin or linezolid if MRSA carriage swab and bacterial respiratory cultures are negative for MRSA. Use IV formulation only if non-functional GI tract.&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;ADD if history of MRSA or high suspicion MRSA&apos;]/items[openEHR-EHR-SECTION.orderable_section.v1 and name/value=&apos;linezolid&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;linezolid Tablet; 600 mg, oral, every 12 hours, for 6 doses, STAT&apos;]/activities[at0001]">
          <items>
            <item>
              <key>CKT.Content Details</key>
              <value>&lt;p&gt;&lt;em&gt;Reassess in 48 to 72 hours.&amp;nbsp;Discontinue vancomycin or linezolid if MRSA carriage swab and bacterial respiratory culture are negative for MRSA.&amp;nbsp;Encouraged for all patients with functional GI tract&lt;/em&gt;&lt;/p&gt;</value>
            </item>
          </items>
        </annotations>
        <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="COVID-19 ICU Antibacterial Therapy">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="Empiric Antimicrobial Therapy of Pneumonia in Hospitalized Suspect COVID-19 Patients">
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #1"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="46facdb5-2f39-40f1-9c04-7f66e4c25df5" concept_name="PHARM cefTRIAXone injection Order" max="1" path="/items" name="cefTRIAXone injection; 1000 mg, Intravenous, daily, for 3 doses. Reassess after 48 to 72 hours. STAT"/>
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="AND doxycycline or AZIthromycin">
              <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="doxycycline oral">
                <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="6c343f9d-ab54-4fd7-8b40-6c42c6356b51" concept_name="PHARM doxycycline Capsule Order" max="1" path="/items" name="doxycycline Capsule; 200 mg, oral, once"/>
                <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by"/>
                <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="6c343f9d-ab54-4fd7-8b40-6c42c6356b51" concept_name="PHARM doxycycline Capsule Order" max="1" path="/items" name="doxycycline Capsule; 100 mg, Oral, 2 times per day, for 5 doses. Starting 12 hours following initial 200 mg dose. Reassess after 48 to 72 hours"/>
              </Item>
              <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
              <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="doxycycline liquid">
                <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fa80ca89-b938-4053-b4ab-6eaf57409b6f" concept_name="PLACEHOLDER Order Item" max="1" path="/items" name="doxycycline oral liquid 5 mg/mL; 200 mg, oral, once, STAT"/>
                <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by"/>
                <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fa80ca89-b938-4053-b4ab-6eaf57409b6f" concept_name="PLACEHOLDER Order Item" max="1" path="/items" name="doxycycline oral liquid 5 mg/mL; 100 mg, oral, 2 times per day for 6 doses,  Starting 12 hours following initial 200 mg dose. Reassess after 48 to 72 hours"/>
              </Item>
              <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR #2"/>
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="87c88028-2aef-4aa9-9d1d-c6f427ed9e45" concept_name="PHARM AZIthromycin injection Order" max="1" path="/items" name="AZIthromycin injection; 500 mg, Intravenous, daily, for 3 doses. Reassess after 48 to 72 hours , STAT"/>
            </Item>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="ADD if history of MRSA or high suspicion MRSA">
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="vancomycin IV">
              <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="84e61dc2-1c30-4dfe-951a-b67f1fd9a910" concept_name="PHARM vancomycin injection Order" max="1" path="/items" name="vancomycin injection; 25 mg/kg/dose, intravenous, once, STAT"/>
              <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed by"/>
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="84e61dc2-1c30-4dfe-951a-b67f1fd9a910" concept_name="PHARM vancomycin injection Order" max="1" path="/items" name="vancomycin injection; 15 mg/kg/dose, intravenous, every 12 hours, for 3 days. Start 12 hours after initial 25 mg/kg/dose dose. Target trough. Reassess in 48 to 72 hours. "/>
            </Item>
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR"/>
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.orderable_section.v1" concept_name="Orderable Section" max="1" path="/items" name="linezolid">
              <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3d7e63db-b139-4aba-aa16-7c732a4b0f77" concept_name="PHARM linezolid injection Order" max="1" path="/items" name="linezolid injection; 600 mg, intravenous, every 12 hours, for 6 doses, STAT"/>
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="60043240-034a-4384-a0f5-fe03ae49dbd3" concept_name="PHARM linezolid Tablet Order" max="1" path="/items" name="linezolid Tablet; 600 mg, oral, every 12 hours, for 6 doses, STAT"/>
            </Item>
          </Item>
        </definition>
        <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
          <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
        </integrity_checks>
        <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
          <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
        </integrity_checks>
        <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.orderable_section.v1">
          <digest id="MD5-CAM-1.0.1">A89AC74BC8CAD3F0719579389C69006F</digest>
        </integrity_checks>
        <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
          <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
        </integrity_checks>
        <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
          <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
        </integrity_checks>
      </template>